These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Bortezomib (PS-341) treatment decreases inflammation and partially rescues the expression of the dystrophin-glycoprotein complex in GRMD dogs. Araujo KP, Bonuccelli G, Duarte CN, Gaiad TP, Moreira DF, Feder D, Belizario JE, Miglino MA, Lisanti MP, Ambrosio CE. PLoS One; 2013 Sep; 8(4):e61367. PubMed ID: 23579193 [Abstract] [Full Text] [Related]
8. Microvessel density in muscles of dogs with golden retriever muscular dystrophy. Nguyen F, Guigand L, Goubault-Leroux I, Wyers M, Cherel Y. Neuromuscul Disord; 2005 Feb; 15(2):154-63. PubMed ID: 15694137 [Abstract] [Full Text] [Related]
15. A comparative study of N-glycolylneuraminic acid (Neu5Gc) and cytotoxic T cell (CT) carbohydrate expression in normal and dystrophin-deficient dog and human skeletal muscle. Martin PT, Golden B, Okerblom J, Camboni M, Chandrasekharan K, Xu R, Varki A, Flanigan KM, Kornegay JN. PLoS One; 2014 Jun; 9(2):e88226. PubMed ID: 24505439 [Abstract] [Full Text] [Related]
16. Muscle function recovery in golden retriever muscular dystrophy after AAV1-U7 exon skipping. Vulin A, Barthélémy I, Goyenvalle A, Thibaud JL, Beley C, Griffith G, Benchaouir R, le Hir M, Unterfinger Y, Lorain S, Dreyfus P, Voit T, Carlier P, Blot S, Garcia L. Mol Ther; 2012 Nov; 20(11):2120-33. PubMed ID: 22968479 [Abstract] [Full Text] [Related]